Moreover, the concurrent increase in IBA1+ microglia and iNOS+ cells in the midbrain of PD patients compared with controls supports the hypothesis that persistent microglial neuroinflammation contributes to disease progression. This evidence concerns the gene NOS2 and Parkinson disease.